Ubiquitin-specific protease 20(USP20) mitigates doxorubicin-induced cardiotoxicity by deubiquitinating and stabilizing HuR
- 30 March 2026
- journal article
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 358, 151642
Abstract
No abstract availableKeywords
Funding Information
- Natural Science Foundation of Zhejiang Province (ZCLMS26H0201)
- Natural Science Foundation of Zhejiang Province (LQ23H310005)
- Wenzhou Medical University
- National Natural Science Foundation of China (82202380)
- National Natural Science Foundation of China (82570459)
- Science and Technology Plan Project of Wenzhou Municipality (Y20210136)
- Health Commission of Zhejiang Province (WKJ-ZJ-2540)
This publication has 28 references indexed in Scilit:
- Angiotension II directly bind P2X7 receptor to induce myocardial ferroptosis and remodeling by activating human antigen RRedox Biology, 2024
- Ferroptosis mechanisms and regulations in cardiovascular diseases in the past, present, and futureCell Biology and Toxicology, 2024
- Idebenone alleviates doxorubicin-induced cardiotoxicity by stabilizing FSP1 to inhibit ferroptosisActa Pharmaceutica Sinica B, 2024
- FTO ameliorates doxorubicin-induced cardiotoxicity by inhibiting ferroptosis via P53–P21/Nrf2 activation in a HuR-dependent m6A mannerRedox Biology, 2024
- USP36-mediated PARP1 deubiquitination in doxorubicin-induced cardiomyopathyCellular Signalling, 2024
- Doxorubicin-conjugated siRNA lipid nanoparticles for combination cancer therapyActa Pharmaceutica Sinica B, 2022
- HuR as a molecular target for cancer therapeutics and immune-related disordersAdvanced Drug Delivery Reviews, 2022
- PRMT5 regulates RNA m6A demethylation for doxorubicin sensitivity in breast cancerMolecular Therapy, 2022
- USP18 protects against hepatic steatosis and insulin resistance through its deubiquitinating activityHepatology, 2017
- Doxorubicin‐Induced Cardiotoxicity: From Bioenergetic Failure and Cell Death to CardiomyopathyMedicinal Research Reviews, 2013